Physician profile
Prosper Benhaim
NPI 1669558615
$492,192.59
in general payments reported to CMS, 2019-2025
10 companies · $94K in 2025
The $94K reported for 2025 was more than what 99% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82K · 2020: $25K · 2021: $55K · 2022: $52K · 2023: $88K · 2024: $96K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $178K · Consulting Fee: $76K · Travel and Lodging: $16K · Food and Beverage: $5,371 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $178,185.00 |
| Consulting Fee | $76,055.31 |
| Travel and Lodging | $16,102.52 |
| Food and Beverage | $5,370.88 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $299,854.81 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $134,750.47 | 2024-2025 | Xiaflex |
| Axogen | $36,355.28 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Medartis INC. | $19,436.45 | 2025 | Aptus |
| Micromed INC | $1,171.26 | 2019-2021 | |
| Trimed, INC. | $290.15 | 2023-2024 | |
| Tela Bio, INC. | $140.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $116.58 | 2019 | |
| Ossur Americas, INC. | $57.00 | 2024 | I-Digits Quantum |
| Integra Lifesciences Corporation | $20.57 | 2023 | Tenoglide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prosper Benhaim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.